本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cartesian Therapeutics

7.86
-0.0500-0.63%
成交量:16.45萬
成交額:130.68萬
市值:2.38億
市盈率:-1.36
高:8.27
開:8.11
低:7.79
收:7.91
52周最高:11.00
52周最低:5.60
股本:3,025.54萬
流通股本:1,240.27萬
量比:1.39
換手率:1.33%
股息:- -
股息率:- -
每股收益(TTM):-5.7983
每股收益(LYR):-5.0200
淨資產收益率:-7029.26%
總資產收益率:-17.43%
市淨率:-1.90
市盈率(LYR):-1.57

資料載入中...

2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/06

SEC問詢函

Form CORRESP - Correspondence
2025/01/06

SEC問詢函

Form CORRESP - Correspondence
2025/01/06

SEC問詢函

Form CORRESP - Correspondence
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/03

重要事件披露

Form 8-K - Current report
2024/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/18

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]